SS Innovations International, Inc. (Nasdaq: SSII), India’s home grown surgical robotics pioneer, today announced a landmark milestone with the submission of its 510(k) premarket notification to the U.S. Food and Drug Administration (FDA) for the company’s next-generation SSi Mantra surgical robotic system. The submission, completed on December 5, 2025, covers multiple high demand surgical specialties including general, urological, colorectal, gynaecological, and cardiac procedures.
The move marks one of the most significant global regulatory steps ever undertaken by an
Indian developed surgical robotic platform, positioning India prominently in a sector long
dominated by international players.
Dr. Sudhir Srivastava, Founder, Chairman, and CEO of SS Innovations, stated: “Submitting our 510(k) notification to the FDA is a defining moment, not only for SS Innovations, but for India’s emergence as a global leader in advanced medical technologies.
The SSi Mantra is designed to be affordable, accessible, and technologically differentiated,
and its proven performance across diverse geographies speaks for itself. We believe all hospitals, particularly those serving underserved communities, stand to benefit immensely
from an option that is both world-class and cost-effective.”
Following a pre submission meeting and detailed consultations with the FDA, the Company
opted for the 510(k) pathway over a De Novo request, seeking to leverage the route’s potential speed and efficiency. The FDA’s target review timeline for 510(k) submissions is 90 days, though total review duration may vary. SS Innovations also continues to advance
toward its European Union CE Marking, expected in the first half of 2026, further accelerating the global footprint of the Made-in-India platform.
As of November 30, 2025, the SSi Mantra has achieved:
138 systems installed across eight countries
137 hospitals actively using the platform
Over 7,300 surgical procedures, including 88 telesurgeries
390 cardiac surgeries, one of the most technically demanding robotic domains
The SSi Mantra’s adoption and performance underscore the rising global confidence in an
indigenous Indian medical robotics ecosystem, an inflection point for India’s med-tech industry.